OMRON, IMA and HCFI partner to address the growing incidences of hypertension

The partnership aims to propagate the importance of regular monitoring of Blood Pressure

OMRON Healthcare India has joined hands with Indian Medical Association (IMA) and Heart Care Foundation of India (HCFI) to create awareness among the masses and healthcare professions about the need for regular monitoring of blood pressure at home.

“Indicated as one of the key lifestyle diseases, it is well evident that Hypertension leads to life-threatening cardio-vascular disorders if not treated well. Despite the whopping numbers, very few Hypertensive patients use BP monitors for regular monitoring at home which is a grim and scary picture. OMRON aims to contribute to the challenge by partnering with the right stakeholders who are looked upon as trustworthy associates by the masses as well as medical practitioners to propagate the importance of blood pressure monitoring as a key part of the overall management of the malady” says Kazunori Tokura, MD, OMRON Healthcare India.

The initiative has started working in this regard by rolling-out many joint activities pan India such as organising health camps providing a platform for holding dialogues with the medical fraternity, on the myths prevailing around home BP monitoring, and free check-ups; disseminating mass communication on the importance of managing blood pressure as one of key vitals for almost all non-communicable diseases and substantiating the utility and efficacy of digital home BP monitors, etc.

Giving more insights, Dr Ravi Wankhedkar, National President, IMA and Dr KK Aggarwal, President, Heart Care Foundation of India reiterated that Hypertension is one of the most significant silent killer amongst Indians. “The association with OMRON is another significant step which IMA and HCFI have taken as the only representative voluntary organisations of Doctors of Modern Scientific System of Medicine to contribute towards the well-being of the community by promoting the utility of advanced medical and allied sciences/ technologies.”